The M2 protein of influenza virus A is a proton-selective ion channel activated by pH. Structure determination by solid-state and solution NMR and X-ray crystallography has contributed significantly to our understanding, but channel activation may involve conformations not captured by these studies. Indeed, solidstate NMR data demonstrate that the M2 protein possesses significant conformational heterogeneity. Here, we report molecular dynamics (MD) simulations of the M2 transmembrane domain (TMD) in the absence and presence of the antiviral drug amantadine. The ensembles of MD conformations for both apo and bound forms reproduced the NMR data well. The TMD helix was found to kink around Gly-34, where water molecules penetrated deeply into the backbone. The amantadine-bound form exhibited a single peak Ϸ10°in the distribution of helix-kink angle, but the apo form exhibited 2 peaks, Ϸ0°and 40°. Conformations of the apo form with small and large kink angles had narrow and wide pores, respectively, around the primary gate formed by His-37 and Trp-41. We propose a structural model for channel activation, in which the small-kink conformations dominate before proton uptake by His-37 from the exterior, and proton uptake makes the large-kink conformations more favorable, thereby priming His-37 for proton release to the interior.solid-state NMR ͉ MD simulations ͉ helix kink ͉ histidine tetrad ͉ amantadine T he M2 protein of influenza virus A is a proton-selective ion channel activated by pH. Its function, proton conductance, is essential for effective replication of the virus. The transmembrane domain (TMD) of this homotetrameric protein contains a single helix (residues Ser-22 to Leu-46) from each subunit. Within the TMD, residues His-37 and Trp-41 constitute the primary gate that is critical for proton conductance and selectivity and pH activation (1-3). On the N-terminal (i.e., virus exterior) side, disulfide bonds involving Cys-17 and Cys-19 provide stabilization (4). On the C-terminal side, an amphiphilic helix may also be involved in pH activation (5). The antiviral drug amantadine and its derivatives inhibit the channel function by putatively binding to the TMD (6-8). The structures of the M2 TMD in the apo form and the amantadine-bound form were first determined by solid-state NMR (9, 10). In addition, extensive experimental (1, 2, 11-16) and computational (17-20) studies have been performed to model the structure of the M2 TMD and understand the molecular mechanisms of conductance and selectivity of the proton channel. Recently, 2 new structures were solved by X-ray crystallography (21) and solution NMR spectroscopy (22). Those 2 studies have generated controversies, especially about the mechanism of drug inhibition. Additional structural results have recently been published that add to the controversies surrounding inhibitor binding (23,24) and the closed-to open-state conformational transition (25).Channel activation may involve conformations not captured by the X-ray and NMR structures. Indeed, solid-state NMR...